Patheon N.V. Ordinary shares, p (PTHN) Stock Price, News & Analysis

Company Overview

Patheon N.V. is a provider of outsourced pharmaceutical development and manufacturing services. The Company's segments include Drug Product Services (DPS), Pharmaceutical Development Services (PDS) and Drug Substance Services (DSS). The DPS segment is engaged in manufacturing and packaging for approved prescription, over-the-counter (OTC) and nutritional products. The PDS segment provides a range of formulation, production and technical services from the early stages of a product's development to regulatory approval, as well as for new formulations of approved products for lifecycle extension. The DSS segment provides small molecule active pharmaceutical ingredient (API) and outsourced manufacturing solutions for large molecule biological API from early development through commercial scale production. It provides an integrated range of API and finished drug product services to its customers, from formulation development to clinical and commercial-scale manufacturing.

Key Stats

• Today's Range: $34.98 to $34.98
• 50-Day Range: N/A
• 52-Week Range: $23.72 to $35.13
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PTHN Stock Analysis - Frequently Asked Questions

How were Patheon N.V. Ordinary shares, p's earnings last quarter?

Patheon N.V. Ordinary shares, p (NYSE:PTHN) posted its quarterly earnings results on Thursday, June, 8th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.19 by $0.01. Patheon N.V. Ordinary shares, p's revenue was up 3.2% compared to the same quarter last year.

When did Patheon N.V. Ordinary shares, p IPO?

Patheon N.V. Ordinary shares, p (PTHN) raised $625 million in an initial public offering on Thursday, July 21st 2016. The company issued 30,500,000 shares at a price of $19.00-$22.00 per share. J.P. Morgan, Morgan Stanley, Jefferies, UBS Investment Bank, Credit Suisse, Evercore ISI and Wells Fargo Securities acted as the underwriters for the IPO and Baird, Piper Jaffray, Raymond James, William Blair, KeyBanc Capital Markets and Leerink Partners were co-managers.

What other stocks do shareholders of Patheon N.V. Ordinary shares, p own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Patheon N.V. Ordinary shares, p investors own include SVB Financial Group (SIVPQ), Skyworks Solutions (SWKS), Wells Fargo & Company (WFC), Alexion Pharmaceuticals (ALXN), NXP Semiconductors (NXPI), Bank of the Ozarks (OZRK) and Coherus BioSciences (CHRS).

Company Calendar

• Last Earnings: 6/08/2017
• Today: 4/27/2025
• Fiscal Year End: 10/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: NYSE:PTHN
• Previous Symbol: NASDAQ:PTHN
• CIK: 1643848
• Web: www.patheon.com
• Phone: 31-20-622-3243
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A